Rabeprazole: quest for the best PPI. - Wikidata - wikimedia - TriplyDB

Rabeprazole: quest for the best PPI.

Rabeprazole: quest for the best PPI.

http://www.wikidata.org/entity/Q43946238

about

Rabeprazole: quest for the best PPI.

http://www.wikidata.org/entity/Q43946238

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Rabeprazole: quest for the best PPI.

@en

Rabeprazole: quest for the best PPI.

@nl

type

label

Rabeprazole: quest for the best PPI.

@en

Rabeprazole: quest for the best PPI.

@nl

prefLabel

Rabeprazole: quest for the best PPI.

@en

Rabeprazole: quest for the best PPI.

@nl

P1433

Q43946238-E1F1DD68-4A14-4E99-B0C0-4304774E4629

P1476

Q43946238-DEF1DD35-950B-4BE0-A098-63B1A376A118

P2093

Q43946238-32EAF01B-07D7-4DAE-851F-779F1B7834C2

P2860

Q43946238-07F388E4-FAA4-43C1-9AC2-3927D967CC19

Q43946238-25BE058E-562A-4CC5-B71B-AF91137F39DA

Q43946238-648A112B-2BFD-414B-B9A1-F8D490602340

Q43946238-A1EEBE46-B5A5-4F6A-B109-73158B873294

Q43946238-B4BD1854-4C96-4736-A56C-ADE8884B36AB

Q43946238-C300A6EE-C8BA-4A82-B3A0-88412FE7A44F

Q43946238-CDACD181-5F61-4FD5-BB6D-57986970C949

Q43946238-E95F8727-51E7-402A-AE5C-CE3022242E27

P304

Q43946238-55C80F85-66A2-4C9D-AE06-6383F75B8BF7

P31

Q43946238-6a7f0a83-e7d5-4888-a623-84d201db7856

Q43946238-E9DD238E-7406-488F-97AE-40CE088A9080

P356

Q43946238-5C0C8518-32F2-4213-B8CB-62556E8B8379

P433

Q43946238-43FF62B6-0E4F-4FA0-ACB3-22A69B1276E8

P478

Q43946238-0CF69016-7D83-4CEA-881A-43C2BD198AC7

P577

Q43946238-4DEF96FD-3B64-480E-A658-E125C3DD5FEF

P698

Q43946238-E355ECEB-DD95-488B-A6EB-21F7F48E2057

P356

P1433

Journal of Gastroenterology

P1476

Rabeprazole: quest for the best PPI.

@en

P2093

Kentaro Sugano

http://www.w3.org/2001/XMLSchema#string

P2860

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole.

Proton pump inhibitors and their drug interactions: an evidence-based approach.

Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal reflux disease.

Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study.

Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group.

Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group.

Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.

Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole.

P304

233-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S005350200028

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11931540

http://www.w3.org/2001/XMLSchema#string